In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand

Leukemia. 1997 Nov;11(11):1862-7. doi: 10.1038/sj.leu.2400822.

Abstract

The in vitro analysis of growth regulation in low-grade B non-Hodgkin's lymphoma (B-NHL) is hampered by the rapid apoptotic death of the malignant B cells ex vivo. A complex culture system, using murine CDw32 transfected fibroblasts (LTK-cells), IL-4 and anti-CD40 mAb, has been established for the propagation of normal mature B cells in vitro. We investigated the influence of the different components of this coculture system on cell survival and apoptosis of B-NHL cells. Nine samples from patients with follicular lymphoma and from eight patients with immunocytoma were analyzed. No cell proliferation of B-NHL cells could be induced in the culture system. However, CDw32-transfected murine fibroblasts most efficiently supported cell viability of B-NHL cells with an increase in cell survival by 114% compared to the control (P = 0.047). IL-4 alone also had a stimulatory effect on cell survival of B-NHL cells after 6 days. In contrast, the soluble recombinant CD40 ligand gp39 and the anti-CD40 mAbs mAb89 and EA-5 did not prolong cell survival. CDw32 transfectants blocked apoptosis of B-NHL cells efficiently from 67% in the control to 16% (P = 0.001). Reduction in apoptosis was accompanied by an elevated bcl-2 protein expression. IL-4 or mAb89 did not further reduce apoptotic cell death in CDw32 transfectant-dependent cocultures. Our data underline the pivotal role of LTK- cells for cell survival of B-NHL cells in vitro. The efficient blockage of apoptosis associated with increased bcl-2 protein expression causes prolonged cell viability of the B-NHL cells.

MeSH terms

  • Aged
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Apoptosis
  • CD40 Antigens / immunology
  • CD40 Ligand
  • Cell Survival / drug effects*
  • Fibroblasts / drug effects
  • Fibroblasts / physiology*
  • Flow Cytometry
  • Genes, bcl-2 / genetics
  • Humans
  • Interleukin-4 / pharmacology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / physiopathology
  • Lymphoma, Follicular / pathology*
  • Lymphoma, Follicular / physiopathology
  • Membrane Glycoproteins / pharmacology
  • Mice
  • Middle Aged
  • Transfection

Substances

  • Antibodies, Monoclonal
  • CD40 Antigens
  • Membrane Glycoproteins
  • CD40 Ligand
  • Interleukin-4